Hologic (HOLX) Tops Q4 EPS by 5c; offers guidance

Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.89, $0.05 better than the analyst estimate of $0.84. Revenue for the quarter came in at $945.3 million versus the consensus estimate of $940.03 million.

GUIDANCE:

Hologic sees Q1 2024 EPS of $0.92-$0.97, versus the consensus of $0.94. Hologic sees Q1 2024 revenue of $960-985 million, versus the consensus of $1017 million.

Hologic sees FY2024 EPS of $3.90-$4.10, versus the consensus of $3.90. Hologic sees FY2024 revenue of $3.92-4.02 billion, versus the consensus of $4.023 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c